labsolutions software ver 5 99 (Shimadzu Corporation)
Shimadzu Corporation is a verified supplier 
Shimadzu Corporation manufactures this product 
99
Structured Review
Shimadzu Corporation
labsolutions software ver 5 99
Labsolutions Software Ver 5 99, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 7932 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/labsolutions+software+ver+5+99/LabSolutions+Series/pmc11963376-1106-7-10
Average 99 stars, based on 7932 article reviews
Labsolutions Software Ver 5 99, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 7932 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/labsolutions+software+ver+5+99/LabSolutions+Series/pmc11963376-1106-7-10
Average 99 stars, based on 7932 article reviews
labsolutions software ver 5 99 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Quantitation Assay:Article Title: Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model Article Snippet: .. Data acquisition and quantitation were performed using Article Title: Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model. Article Snippet: Aldo-keto reductase 1C3 (AKR1C3) is overexpressed in castration-resistant prostate cancer where it acts to drive proliferation and aggressiveness by producing androgens.. The reductive action of the enzyme leads to chemoresistance development against various clinical antineoplastics across a range of cancers.. Herein, we report the continued optimization of selective AKR1C3 inhibitors and the identification of 5r, a potent AKR1C3 inhibitor (IC50 = 51 nM) with >1216-fold selectivity for AKR1C3 over closely related isoforms. Software:Article Title: Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model Article Snippet: .. Data acquisition and quantitation were performed using Article Title: Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model. Article Snippet: Aldo-keto reductase 1C3 (AKR1C3) is overexpressed in castration-resistant prostate cancer where it acts to drive proliferation and aggressiveness by producing androgens.. The reductive action of the enzyme leads to chemoresistance development against various clinical antineoplastics across a range of cancers.. Herein, we report the continued optimization of selective AKR1C3 inhibitors and the identification of 5r, a potent AKR1C3 inhibitor (IC50 = 51 nM) with >1216-fold selectivity for AKR1C3 over closely related isoforms. |